Bibliography

Pulmonary

2017

Homeobox, Wnt, and Fibroblast Growth Factor Signaling is Augmented During Alveogenesis in Mice Lacking Superoxide Dismutase 3, Extracellular (2017) Thimraj TA, Birru RL, Mitra A, Schulz H, Leikauf GD, Ganguly K Lung
 
Therapy Indications
 

Cigarette smoke disrupts monolayer integrity by altering epithelial cell-cell adhesion and cortical tension. (2017) Nishida K, Brune KA, Putcha N, Mandke P, O'Neal WK, Shade D, Srivastava V, Wang M, Lam H, An SS, Drummond MB, Hansel NN, Robinson DN, Sidhaye VK. Am J Physiol Lung Cell Mol Physiol
 
Therapy Indications
 

Complexity of Macrophage Migration Inhibitory Factor (MIF) and Other Angiogenic Biomarkers Profiling in Pulmonary Arterial Hypertension. (2017) Marshall JD, Sauler M, Tonelli A, Rao Y, Bucala R, Lee P, Fares W Pulm Circ.
 
Therapy Indications
 

Back To Top

2016

Predictors of Asthma Following Severe Respiratory Syncytial Virus (Rsv) Bronchiolitis in Early Childhood (2016) Lu S, Hartert TV, Everard ML, Giezek H, Nelsen L, Mehta A, Patel H, Knorr B, Reiss TF Pediatric Pulmonology
 
Therapy Indications
 

Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts. (2016) Keene JD, Jacobson S, Kechris K, Kinney GL, Foreman MG, Doerschuk CM, Make BJ, Curtis JL, Rennard SI, Barr RG, Bleecker ER, Kanner RE, Kleerup EC, Hansel NN, Woodruff PG, Han MK, Paine Iii R, Martinez FJ, Bowler RP, O'Neal WK; for COPDGene and SPIROMICS Investigators. Am J Respir Crit Care Med.
 
Therapy Indications
 

Do Single or Sequential Measurements of Leptin and Adiponectin in Plasma Have Prognostic Value in Pulmonary Arterial Hypertension? (2016) Tonelli AR, Fares WH, Dakkak W, Rao Y, Dweik RA Pulmonary Circulation
 
Therapy Indications
 

Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma (2016) Bateman ED, Goehring UM, Richard F, Watz H Journal of Allergy and Clinical Immunology
 
Therapy Indications
 

Comprehensive Systems Biology Analysis of a 7-Month Cigarette Smoke Inhalation Study in C57bl/6 (2016) Ansari S, Baumer K, Boué S, Dijon S, Dulize R, Ekroos K, Elamin A, Foong C, Guedj E, Hoeng J, Ivanov NV, Krishnan S, Leroy P, Martin F, Merg C, Peck MJ, Peitsch MC, Phillips B, Schlage WK, Schneider T, Talikka M, Titz B, Vanscheeuwijck P, Veljkovic E, Vihervaara T, Vuillaume G, Woon CQ Scientific Data
 
Therapy Indications
 

Evaluation of the Tobacco Heating System 2.2. Part 4: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects compared with cigarette smoke (2016) Wong ET, Kogel U, Veljkovic E, Martin F, Xiang Y, Boue S, Vuillaume G, Leroy P, Guedj E, Rodrigo G, Ivanov NV, Hoeng J, Peitsch MC, Vanscheeuwijck P. Regul Toxicol Pharmacol.
 
Therapy Indications
 

Evaluation of the Tobacco Heating System 2.2. Part 6: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects of a mentholated version compared with mentholated and non-mentholated cigarette smoke (2016) Oviedo A, Lebrun S, Kogel U, Ho J, Tan WT, Titz B, Leroy P, Vuillaume G, Bera M, Martin F, Rodrigo G, Esposito M, Dempsey R, Ivanov NV, Hoeng J, Peitsch MC, Vanscheeuwijck P. Regul Toxicol Pharmacol.
 
Therapy Indications
 

A Sputum Proteomic Signature That Associates with Increased Il-1? Levels and Bacterial Exacerbations of COPD (2016) Damera G, Pham T-H, Zhang J, Ward CK, Newbold P, Ranade K, Sethi S Lung

Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children (2016) Stein MM, Hrusch CL, Gozdz J, Igartua C, Pivniouk V, Murray SE, Ledford JG, Marques Dos Santos M, Anderson RL, Metwali N, Neilson JW, Maier RM, Gilbert JA, Holbreich M, Thorne PS, Martinez FD, Von Mutius E, Vercelli D, Ober C, Sperling AI New England Journal of Medicine

Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD (2016) Sun W, Kechris K, Jacobson S, Drummond MB, Hawkins GA, Yang J, Chen T-H, Quibrera PM, Anderson W, Barr RG, Basta PV, Bleecker ER, Beaty T, Casaburi R, Castaldi P, Cho MH, Comellas A, Crapo JD, Criner G, Demeo D, Christenson SA, Couper DJ, Curtis JL, Doerschuk CM, Freeman CM, Gouskova NA, Han MK, Hanania NA, Hansel NN, Hersh CP, Hoffman EA, Kaner RJ, Kanner RE, Kleerup EC, Lutz S, Martinez FJ, Meyers DA, Peters SP, Regan EA, Rennard SI, Scholand MB, Silverman EK, Woodruff PG, O’neal WK, Bowler RP, Group SR, Investigators CO PLOS Genetics
 
Therapy Indications
 

Back To Top

2015

Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods. (2015) Morrow JD, Qiu W, Chhabra D, Rennard SI, Belloni P, Belousov A, Pillai SG, Hersh CP. BMC Med Genomics. 2015 Jan 13;8(1):1. [Epub ahead of print]
 
Therapy Indications
 

The long-acting ß2-agonist olodaterol attenuates pulmonary inflammation. (2015) Wex E, Kollak I, Duechs MJ, Naline E, Wollin L, Devillier P. Br J Pharmacol. 2015 Mar 30. doi: 10.1111/bph.13143. [Epub ahead of print]

A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco product. (2015) Phillips B, Veljkovic E, Peck MJ, Buettner A, Elamin A, Guedj E, Vuillaume G, Ivanov NV, Martin F, Bouéb S, Schlage WK, Schneider T, Titz B, Talikka M, Vanscheeuwijck P, Hoeng J, Peitsch MC. Food Chem Toxicol. 2015 Apr 2. pii: S0278-6915(15)00088-5. doi: 10.1016/j.fct.2015.03.009. [Epub ahead of print]

The Effect Trial: Evaluating Exacerbations, Biomarkers, and Safety Outcomes with Two Dose Levels of Fluticasone Propionate/Formoterol in Copd (2015) Papi A, Jones PW, Dalvi PS, Mcaulay K, Mciver T, Dissanayake S International Journal of COPD
 
Therapy Indications
 

Back To Top

2014

Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertension (2014) Kolli MB, Manne ND, Para R, Nalabotu SK, Nandyala G, Shokuhfar T, He K, Hamlekhan A, Ma JY, Wehner PS, Dornon L, Arvapalli R, Rice KM, Blough ER. Biomaterials. 2014 Sep 12. pii: S0142-9612(14)00962-4. doi: 10.1016/j.biomaterials.2014.08.037. [Epub ahead of print]
 
Therapy Indications
 

Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study (2014) O'Neal WK, Anderson W, Basta PV, Carretta EE, Doerschuk CM, Barr RG, Bleecker ER, Christenson SA, Curtis JL, Han MK, Hansel NN, Kanner RE, Kleerup EC, Martinez FJ, Miller BE, Peters SP, Rennard SI, Scholand MB, Tal-Singer R, Woodruff PG, Couper DJ, Davis SM J Transl Med. 2014 Jan 8;12(1):9
 
Therapy Indications
Miscellaneous
Pulmonary
 

Targeting glycosaminoglycans in the lung by an engineered CXCL8 as a novel therapeutic approach to lung inflammation (2014) Adage T, Konya V, Weber C, Strutzmann E, Fuchs T, Zankl C, Gerlza T, Jeremic D, Heinemann A, Kungl AJ. Eur J Pharmacol. 2014 Dec 29. pii: S0014-2999(14)00889-9. doi: 10.1016/j.ejphar.2014.12.019. [Epub ahead of print]

The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes (2014) Carolan BJ, Hughes G, Morrow J, Hersh CP, O'Neal WK, Rennard S, Pillai SG, Belloni P, Cockayne DA, Comellas AP, Han M, Zemans RL, Kechris K, Bowler RP. Respiratory Research 2014 Oct 12;15(1):127. doi: 10.1186/s12931-014-0127-9.
 
Therapy Indications
 

A prospective assessment of the effect of aminophylline therapy on urine output and inflammation in critically ill children (2014) Tamburro RF, Thomas NJ, Ceneviva GD, Dettorre MD, Brummel GL, Lucking SE Front. Pediatr. 2:59

Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease. (2014) Suzuki M, Makita H, Ostling J, Thomsen LH, Konno S, Nagai K, Shimizu K, Pedersen JH, Ashraf H, Bruijnzeel PL, Maciewicz RA, Nishimura M; for the Hokkaido COPD cohort study and DLCST investigators. Ann Am Thorac Soc. 2014 Nov 5. [Epub ahead of print]
 
Therapy Indications
 

Multi-analyte profiling of inflammatory mediators in COPD sputum – The effects of processing (2014) Pedersen F, Holz O, Lauer G, Quintini G, Kiwull-Schone H, Kirsten A-M, Magnussen H, Rabe KF, Goldmann T, Watz H Cytokine. 2014 Nov 15. doi:10.1016/j.cyto.2014.10.008
 
Therapy Indications
 

Effects of acute inhalation of aerosols generated during resistance spot welding with mild-steel on pulmonary, vascular and immune responses in rats. (2014) Zeidler-Erdely PC, Meighan TG, Erdely A, Fedan JS, Thompson JA, Bilgesu S, Waugh S, Anderson S, Marshall NB, Afshari A, McKinney W, Frazer DG, Antonini JM. Inhalation Toxicology 2014 Aug 20:1-11. [Epub ahead of print]
 
Therapy Indications
 

Back To Top

2013

C-Type Lectin Receptor Clec4d Plays a Protective Role in Resolution of Gram-Negative Pneumonia (2013) Steichen AL, Binstock BJ, Mishra BB, Sharma J Journal of Leukocyte Biology

Systemic sRAGE is a Biomarker of Emphysema and Associated with AGER Genetic Variants in COPD Patients (2013) Cheng DT, Kim DK, Cockayne DA, Belousov A, Bitter H, Cho, MH, Duvoix A, Edwards LD, Lomas DA, Miller BE, Reynaert N, Tal-Singer R, Wouters E, Agusti A, Fabbri LM, Rames A, Visvanathan S, Rennard SI, Jones P, Parmar H, MacNee W, Wolff G, Silverman EK, Mayer RJ, Pillai SG, and on Behalf of the TESRA and ECLIPSE Investigators American Journal of Respiratory And Critical Care Medicine ja (2013)

Back To Top

2012

Characterization of AQX-1125, a small molecule SHIP1 activator Part 2. Efficacy studies in allergic and pulmonary inflammation models in vivo (2012) Stenton GR, Mackenzie LF, Tam P, Cross JL, Harwig C, Raymond J, Toews J, Chernoff D, Macrury T, Szabo C Br J Pharmacol. 2012 Nov 2

Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity (2012) Cockayne DA, Cheng DT, Waschki B, Sridhar S, Ravindran P, Hilton H, Kourteva G, Bitter H, Pillai SG, Visvanathan S, Müller KC, Holz O, Magnussen H, Watz H, Fine JS PLoS One. 2012;7(6):e38629

Back To Top

2011

Relationship between pulmonary and systemic markers of exposure to multiple types of welding particulate matter (2011) Erdely A, Salmen-Muniz R, Liston A, Hulderman T, Zeidler-Erdely PC, Antonini JM, Simeonova PP Toxicology

Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis (2011) Richards TJ, Kaminski N, Baribaud F, Flavin S, Brodmerkel C, Horowitz D, Li K, Choi J, Vuga LJ, Lindell KO, Klesen M, Zhang Y, Gibson KF Am J Respir Crit Care Med. 2011 Oct 20. [Epub ahead of print]
 
Therapy Indications
Miscellaneous
Pulmonary
 

Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis (2011) Ohashi K, Sato A, Takada T, Arai T, Nei T, Kasahara Y, Motoi N, Hojo M, Urano S, Ishii H, Yokoba M, Eda R, Nakayama H, Nasuhara Y, Tsuchihashi Y, Kaneko C, Kanazawa H, Ebina M, Yamaguchi E, Kirchner J, Inoue Y, Nakata K, Tazawa R Respir Med. 2011 Nov 22. [Epub ahead of print]

Inflammatory profile and response to anti-TNF therapy in patients with chronic pulmonary sarcoidosis (2011) Loza MJ, Brodmerkel C, Du Bois RM, Judson MA, Costabel U, Drent M, Kavuru M, Flavin S, Lo KH, Barnathan ES, Baughman RP Clin Vaccine Immunol. 2011 Apr 20. [Epub ahead of print]

Back To Top

2010

Identification of distinct plasma biomarker signatures in patients with rapid and slow declining forms of COPD (2010) Devanarayan V, Scholand MB, Hoidal J, Leppert MF, Crackower MA, O'Neill GP, Gervais FG COPD 7: 51-58.

Multi analyte profiling and variability of inflammatory markers in blood and induced sputum in patients with stable COPD (2010) Aaron SD, Vandemheen KL, Ramsay T, Zhang C, Avnur Z, Nikolcheva T, Quinn A Respir Res. 2010 Apr 22;11:41

Peripheral Blood Biomarkers Predict Disease Progression And Mortality In IPF (2010) Richards TJ, Lindell KO, Klesen M, Kaminski N, Zhang Y, Gibson KF Am J Respir Crit Care Me 181: A1120.

Back To Top

2009

Lethal Pulmonary Infection with Francisella Novicida is Associated with Severe Sepsis. (2009) Sharma J, Li Q, Mishra BB, Pena C, Teale JM J Leukoc Biol 86: 491-504.

Back To Top

2008

Mechanisms of oncostatin M-induced pulmonary inflammation and fibrosis. (2008) Mozaffarian A, Brewer AW, Trueblood ES, Luzina IG, Todd NW, Atamas SP, Arnett HA J Immunol 181: 7243-7253.

Back To Top

2007

Eotaxin-1/CC chemokine ligand 11: a novel eosinophil survival factor secreted by human pulmonary artery endothelial cells (2007) Farahi N, Cowburn AS, Upton PD, Deighton J, Sobolewski A, Gherardi E, Morrell NW, Chilvers ER J Immunol. 2007 Jul 15;179(2):1264-73